News - Page 3

June 14, 2023

Today is MedComms Day!

MedComms Day 2023 is special for us because this year marks the 20th anniversary of Marielle Romet taking over as the head of Santé Active Edition, parent company of the Santé Active Edition – Synergy Pharm group, specializing in medical and scientific writing.

May 16, 2023

Skin cancer (or cutaneous cancer) is one of the most preventable types of cancer because the risk factors are well established. In addition, its onset and development are usually visible at an early stage, and it can be detected by self-examination. However, the global worldwide incidence of skin cancer continues to rise. Campaigns have therefore been implemented to raise awareness among the general population and better prevent this type of cancer.

April 7, 2023

World Health Day is celebrated every year on April, 7. In 2023, this date also marks the 75th anniversary of the World Health Organization (WHO). This is an opportunity to look back at the history of the WHO and advances in public health, and to talk about the contribution of our medical writing agency to some of these programs.

March 13, 2023

The 25^th edition of La Semaine du Cerveau (Brain Awareness Week) is taking place this week (13^th to 19^th of March 2023), providing an opportunity to learn more about the brain and discover recent advances in neuroscience research.

February 27, 2023

If you follow our news, you know that rare diseases are one of the areas of expertise of our medical writing team.

At Santé Active Edition – Synergy Pharm, we are therefore particularly keen to express our support to patients and all those involved in the fight against rare diseases on Rare Disease Day.

February 10, 2023

What is epilepsy?

Epilepsy is a neurological disease affecting approximately 50 million people worldwide. It affects both men and women, regardless of race, ethnicity and age.

January 27, 2023

Research and drug development for rare diseases are often hampered by the need for large numbers of patients to assess clinical trial outcomes and, in the case of rare neurodegenerative diseases, by slow disease progression. In particular, the “by eye” behavioral assessments currently used to monitor disease progression require long-term observation to detect changes in patient status, may be subject to observer bias, and can lack the precision needed to detect small but clinically relevant alterations in functional capabilities.

January 12, 2023

End of the first transition period for the new Clinical Trials Regulation

One year after it came into force, the new Clinical Trials Regulation (Regulation (EU) No 536/2014) will become mandatory for all initial clinical trial applications from Member States of the European Union (EU) or the European Economic Area (EEA), which includes the 27 Member States of the EU*, as well as Iceland, Norway and Liechtenstein.
*Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, Germany, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden.

December 13, 2022

• Can we avoid the illnesses and disabilities linked to old age?

• Is it possible to reverse or prevent the signs of aging?

• Are there any simple and cheap anti-aging strategies that can be used by everyone?

November 14, 2022

Diabetes: a major global health issue

Diabetes (Diabetes Mellitus) is a chronic metabolic disease characterized by high levels of glucose in the blood due to deficient production of insulin by the pancreas or ineffective tissue responses to insulin.

It is one of the most rapidly growing global health emergencies, with the latest figures from the International Diabetes Federation (IDF) Atlas indicating that 10.5% of the world’s population (around 537 million people aged 20–79 years) are currently living with diabetes. This number is predicted to rise to 643 million (11.3%) by 2030 and to 783 million (12.2%) by 2045.